379 related articles for article (PubMed ID: 24559141)
1. Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?
Tan SM; de Haan JB
Redox Rep; 2014 May; 19(3):107-17. PubMed ID: 24559141
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.
Ungvari Z; Bagi Z; Feher A; Recchia FA; Sonntag WE; Pearson K; de Cabo R; Csiszar A
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H18-24. PubMed ID: 20418481
[TBL] [Abstract][Full Text] [Related]
3. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Nezu M; Suzuki N; Yamamoto M
Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
[TBL] [Abstract][Full Text] [Related]
4. Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.
Li B; Liu S; Miao L; Cai L
Exp Diabetes Res; 2012; 2012():216512. PubMed ID: 22645602
[TBL] [Abstract][Full Text] [Related]
5. Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function.
Jiang X; Bai Y; Zhang Z; Xin Y; Cai L
Toxicol Appl Pharmacol; 2014 Sep; 279(2):198-210. PubMed ID: 24967692
[TBL] [Abstract][Full Text] [Related]
6. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
[TBL] [Abstract][Full Text] [Related]
7. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
Saito H
Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats.
Nakai K; Fujii H; Kono K; Goto S; Kitazawa R; Kitazawa S; Hirata M; Shinohara M; Fukagawa M; Nishi S
Am J Hypertens; 2014 Apr; 27(4):586-95. PubMed ID: 24025724
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression.
Liu Y; Chan F; Sun H; Yan J; Fan D; Zhao D; An J; Zhou D
Eur J Pharmacol; 2011 Jan; 650(1):130-7. PubMed ID: 20951123
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells.
Kode A; Rajendrasozhan S; Caito S; Yang SR; Megson IL; Rahman I
Am J Physiol Lung Cell Mol Physiol; 2008 Mar; 294(3):L478-88. PubMed ID: 18162601
[TBL] [Abstract][Full Text] [Related]
11. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
Aminzadeh MA; Reisman SA; Vaziri ND; Khazaeli M; Yuan J; Meyer CJ
Xenobiotica; 2014 Jun; 44(6):570-8. PubMed ID: 24195589
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation.
Zhao Y; Song W; Wang Z; Wang Z; Jin X; Xu J; Bai L; Li Y; Cui J; Cai L
Redox Biol; 2018 Apr; 14():609-617. PubMed ID: 29154192
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease.
Vaziri ND; Liu S; Farzaneh SH; Nazertehrani S; Khazaeli M; Zhao YY
Free Radic Biol Med; 2015 Sep; 86():374-81. PubMed ID: 25930007
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling.
Palsamy P; Subramanian S
Biochim Biophys Acta; 2011 Jul; 1812(7):719-31. PubMed ID: 21439372
[TBL] [Abstract][Full Text] [Related]
16. Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives.
Tanase DM; Gosav EM; Anton MI; Floria M; Seritean Isac PN; Hurjui LL; Tarniceriu CC; Costea CF; Ciocoiu M; Rezus C
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139066
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy.
Zhong Q; Mishra M; Kowluru RA
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3941-8. PubMed ID: 23633659
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 protects pancreatic β-cells from oxidative and nitrosative stress in diabetic model mice.
Yagishita Y; Fukutomi T; Sugawara A; Kawamura H; Takahashi T; Pi J; Uruno A; Yamamoto M
Diabetes; 2014 Feb; 63(2):605-18. PubMed ID: 24186865
[TBL] [Abstract][Full Text] [Related]
19. Role of pterostilbene in attenuating immune mediated devastation of pancreatic beta cells via Nrf2 signaling cascade.
Sireesh D; Ganesh MR; Dhamodharan U; Sakthivadivel M; Sivasubramanian S; Gunasekaran P; Ramkumar KM
J Nutr Biochem; 2017 Jun; 44():11-21. PubMed ID: 28343084
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of redox-sensitive Nrf2-Keap1 pathway in diabetes.
Bhakkiyalakshmi E; Sireesh D; Rajaguru P; Paulmurugan R; Ramkumar KM
Pharmacol Res; 2015 Jan; 91():104-14. PubMed ID: 25447793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
